Kiniksa Pharmaceuticals International Total Liabilities (Quarterly) Analysis

Kiniksa Pharmaceuticals International PLC (KNSA)

22.03 +0.55 (+2.56%) USD | NASDAQ | Nov 05, 16:00

22.03 0.00 (0.00%) After-Hours: 20:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2024	118.29M
June 30, 2024	107.33M
March 31, 2024	87.78M
December 31, 2023	87.48M
September 30, 2023	77.94M
June 30, 2023	72.68M
March 31, 2023	52.77M
December 31, 2022	63.52M
September 30, 2022	75.94M
June 30, 2022	57.08M
March 31, 2022	64.72M
December 31, 2021	47.76M
September 30, 2021	38.81M
June 30, 2021	43.42M

Date	Value
March 31, 2021	40.46M
December 31, 2020	37.53M
September 30, 2020	25.90M
June 30, 2020	21.02M
March 31, 2020	20.27M
December 31, 2019	29.11M
September 30, 2019	29.89M
June 30, 2019	32.94M
March 31, 2019	39.64M
December 31, 2018	42.70M
September 30, 2018	28.19M
June 30, 2018	23.33M
March 31, 2018	19.30M
December 31, 2017	137.20M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

20.27M

Minimum

Mar 2020

118.29M

Maximum

Sep 2024

58.49M

Average

54.92M

Median

Total Liabilities (Quarterly) Benchmarks

OPKO Health Inc	584.55M
Ligand Pharmaceuticals Inc	91.21M
Organon & Co	12.26B
NovaBay Pharmaceuticals Inc	4.542M
Palatin Technologies Inc	10.85M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	555.30M
Shareholders Equity (Quarterly)	437.01M
Current Ratio	3.244